Cargando…
New insights into the role of TREM2 in Alzheimer’s disease
Alzheimer’s disease (AD) is the leading cause of dementia. The two histopathological markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and neurofibrillary tangles of aggregated, abnormally hyperphosphorylated tau protein. The majority of AD cases are late-onset, after the age...
Autores principales: | Gratuze, Maud, Leyns, Cheryl E. G., Holtzman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302500/ https://www.ncbi.nlm.nih.gov/pubmed/30572908 http://dx.doi.org/10.1186/s13024-018-0298-9 |
Ejemplares similares
-
TREM2 function impedes tau seeding in neuritic plaques
por: Leyns, Cheryl E.G., et al.
Publicado: (2019) -
Insights from new in vivo models of TREM2 variants
por: Jain, Nimansha, et al.
Publicado: (2023) -
Glial contributions to neurodegeneration in tauopathies
por: Leyns, Cheryl E. G., et al.
Publicado: (2017) -
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
por: Leyns, Cheryl E. G., et al.
Publicado: (2017) -
The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
por: Wolfe, Cody M., et al.
Publicado: (2018)